Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Total Non-Current Liabilities (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 12 years of Total Non-Current Liabilities data on record, last reported at $860.2 million in Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities rose 8.82% year-over-year to $860.2 million; the TTM value through Sep 2025 reached $860.2 million, up 8.82%, while the annual FY2024 figure was $824.2 million, 3.12% down from the prior year.
  • Total Non-Current Liabilities reached $860.2 million in Q3 2025 per AMPH's latest filing, up from $830.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $942.3 million in Q3 2023 and bottomed at $185.0 million in Q2 2021.
  • Average Total Non-Current Liabilities over 5 years is $539.1 million, with a median of $771.4 million recorded in 2023.
  • Peak YoY movement for Total Non-Current Liabilities: soared 338.27% in 2023, then dropped 16.11% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $210.4 million in 2021, then fell by 5.51% to $198.8 million in 2022, then surged by 328.03% to $850.8 million in 2023, then dropped by 3.12% to $824.2 million in 2024, then rose by 4.37% to $860.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $860.2 million in Q3 2025, $830.1 million in Q2 2025, and $850.6 million in Q1 2025.